Headquartered in London (UK), Stallergenes Greer is a fully integrated global biopharmaceutical company specialising in the diagnosis and treatment of allergies.
A WORLDWIDE ALLERGY COMPANY

Press release
April 23, 2018
Notification to Stallergenes Greer Shareholders of Annual General Meeting on 7 June 2018
All press releases Follow us on Twitter